These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2249329)

  • 1. Intratumoural administration of cisplatin in slow-release devices. I. Tumour response and toxicity.
    Deurloo MJ; Bohlken S; Kop W; Lerk CF; Hennink W; Bartelink H; Begg AC
    Cancer Chemother Pharmacol; 1990; 27(2):135-40. PubMed ID: 2249329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoural administration of cisplatin in slow-release devices: II. Pharmacokinetics and intratumoural distribution.
    Deurloo MJ; Kop W; van Tellingen O; Bartelink H; Begg AC
    Cancer Chemother Pharmacol; 1991; 27(5):347-53. PubMed ID: 1998994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of combined modality therapy with cisplatin and radiation using intratumoral drug administration in murine tumors.
    Begg AC; Deurloo MJ; Kop W; Bartelink H
    Radiother Oncol; 1994 May; 31(2):129-37. PubMed ID: 8066192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of differential toxicity between tumor and normal tissues using intratumoral injection with or without a slow-drug-release matrix system.
    Begg AC; Bartelink H; Stewart FA; Brown DM; Luck EE
    NCI Monogr; 1988; (6):133-6. PubMed ID: 3352754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cisplatin slow-release hydrogel drug delivery system based on a formulation of the macrocycle cucurbit[7]uril, gelatin and polyvinyl alcohol.
    Oun R; Plumb JA; Wheate NJ
    J Inorg Biochem; 2014 May; 134():100-5. PubMed ID: 24595010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid tumour chemotherapy using implantable collagen-poly (HEMA) hydrogel containing 5-fluorouracil.
    Jeyanthi R; Nagarajan B; Rao KP
    J Pharm Pharmacol; 1991 Jan; 43(1):60-2. PubMed ID: 1676066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel.
    Konishi M; Tabata Y; Kariya M; Suzuki A; Mandai M; Nanbu K; Takakura K; Fujii S
    J Control Release; 2003 Oct; 92(3):301-13. PubMed ID: 14568411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor treatment by sustained intratumoral release of cisplatin: effects of drug alone and combined with radiation.
    Yapp DT; Lloyd DK; Zhu J; Lehnert SM
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):497-504. PubMed ID: 9308956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system.
    Ning S; Yu N; Brown DM; Kanekal S; Knox SJ
    Radiother Oncol; 1999 Feb; 50(2):215-23. PubMed ID: 10368046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of murine tumors to matrix-associated cisplatin intratumoral implants.
    Yu NY; Conley FK; Luck EE; Brown DM
    NCI Monogr; 1988; (6):137-40. PubMed ID: 3352755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cis-diamminedichloroplatinum(II) treatment at elevated temperatures on murine fibrosarcoma, FSa-II.
    Urano M; Kahn J; Kenton LA
    Int J Hyperthermia; 1990; 6(3):563-70. PubMed ID: 2376669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin delivery by biodegradable polymer implant is superior to systemic delivery by osmotic pump or i.p. injection in tumor-bearing mice.
    Yapp DT; Lloyd DK; Zhu J; Lehnert SM
    Anticancer Drugs; 1998 Oct; 9(9):791-6. PubMed ID: 9840725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Custom Radiopaque Thermoresponsive Chemotherapy-Loaded Hydrogel for Intratumoural Injection: An In Vitro and Ex Vivo Assessment of Imaging Characteristics and Material Properties.
    Rossi SM; Murray TE; Cassidy J; Lee MJ; Kelly HM
    Cardiovasc Intervent Radiol; 2019 Feb; 42(2):289-297. PubMed ID: 30390105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic effects of cisplatin microspheres on peritoneal carcinomatosis in rodents.
    Hagiwara A; Takahashi T; Kojima O; Yamaguchi T; Sasabe T; Lee M; Sakakura C; Shoubayashi S; Ikada Y; Hyon SH
    Cancer; 1993 Feb; 71(3):844-50. PubMed ID: 8431867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irinotecan-loaded double-reversible thermogel with improved antitumor efficacy without initial burst effect and toxicity for intramuscular administration.
    Din FU; Kim DW; Choi JY; Thapa RK; Mustapha O; Kim DS; Oh YK; Ku SK; Youn YS; Oh KT; Yong CS; Kim JO; Choi HG
    Acta Biomater; 2017 May; 54():239-248. PubMed ID: 28285074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in perfusion of mouse tumours after photodynamic therapy.
    van Geel IP; Oppelaar H; Oussoren YG; Stewart FA
    Int J Cancer; 1994 Jan; 56(2):224-8. PubMed ID: 8314306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo.
    Gianasi E; Wasil M; Evagorou EG; Keddle A; Wilson G; Duncan R
    Eur J Cancer; 1999 Jun; 35(6):994-1002. PubMed ID: 10533484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization to radiation from an implanted 125I source by sustained intratumoral release of chemotherapeutic drugs.
    Berrada M; Yang Z; Lehnert SM
    Radiat Res; 2004 Jul; 162(1):64-70. PubMed ID: 15222800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumour response and nephrotoxicity following intraperitoneal administration of a slow release formulation of cisplatin to rats bearing cancers restricted to the peritoneal cavity.
    Los G; Kop W; Deurloo MJ
    Br J Cancer; 1991 Jul; 64(1):90-2. PubMed ID: 1854631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.